155 related articles for article (PubMed ID: 31053856)
1. Intraoperative Monitoring of Heparin: Comparison of Activated Coagulation Time and Whole Blood Heparin Measurements by Different Point-of-Care Devices with Heparin Concentration by Laboratory-Performed Plasma Anti-Xa Assay.
Thompson TZ; Kunak RL; Savage NM; Agarwal S; Chazelle J; Singh G
Lab Med; 2019 Oct; 50(4):348-356. PubMed ID: 31053856
[TBL] [Abstract][Full Text] [Related]
2. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
[TBL] [Abstract][Full Text] [Related]
3. Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliability.
Dirkmann D; Nagy E; Britten MW; Peters J
BMC Anesthesiol; 2019 Sep; 19(1):174. PubMed ID: 31492108
[TBL] [Abstract][Full Text] [Related]
4. Thromboprophylaxis With Heparin During Orthotopic Liver Transplantation: Comparison of Hepcon HMS Plus and Anti-Xa Assays for Low-Range Heparin.
Nicolau-Raducu R; Occhipinti E; Marshall T; Koveleskie J; Ganier D; Evans B; Daly W; Fish B; Cohen AJ; Reichman TW; Bruce D; Bohorquez H; Seal J; Ahmed E; Carmody I; Loss G; Rayburn J; Nossaman B
J Cardiothorac Vasc Anesth; 2017 Apr; 31(2):575-581. PubMed ID: 27745797
[TBL] [Abstract][Full Text] [Related]
5. Heparin monitoring during cardiac surgery. Part 1: Validation of whole-blood heparin concentration and activated clotting time.
Raymond PD; Ray MJ; Callen SN; Marsh NA
Perfusion; 2003 Sep; 18(5):269-76. PubMed ID: 14604242
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test.
Paniccia R; Fedi S; Carbonetto F; Noferi D; Conti P; Bandinelli B; Giusti B; Evangelisti L; Pretelli P; Palmarini MF; Abbate R; Prisco D
Anesthesiology; 2003 Jul; 99(1):54-9. PubMed ID: 12826842
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Heparin Anticoagulation Measured Using i-STAT and Hemochron Activated Clotting Time.
Maslow A; Chambers A; Cheves T; Sweeney J
J Cardiothorac Vasc Anesth; 2018 Aug; 32(4):1603-1608. PubMed ID: 29503117
[TBL] [Abstract][Full Text] [Related]
8. Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation.
Chia S; Van Cott EM; Raffel OC; Jang IK
Thromb Haemost; 2009 Mar; 101(3):535-40. PubMed ID: 19277416
[TBL] [Abstract][Full Text] [Related]
9. Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure.
Dieplinger B; Egger M; Luft C; Hinterreiter F; Pernerstorfer T; Haltmayer M; Mueller T
J Vasc Surg; 2018 Aug; 68(2):400-407. PubMed ID: 29571622
[TBL] [Abstract][Full Text] [Related]
10. The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: a pilot investigation.
Koster A; Despotis G; Gruendel M; Fischer T; Praus M; Kuppe H; Levy JH
Anesth Analg; 2002 Jul; 95(1):26-30, table of contents. PubMed ID: 12088937
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation monitoring during vascular surgery: accuracy of the Hemochron low range activated clotting time (ACT-LR).
Tremey B; Szekely B; Schlumberger S; François D; Liu N; Sievert K; Fischler M
Br J Anaesth; 2006 Oct; 97(4):453-9. PubMed ID: 16873382
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Point-of-Care ACT Coagulometers and Anti-Xa Activity During Cardiopulmonary Bypass.
Falter F; MacDonald S; Matthews C; Kemna E; Cañameres J; Besser M
J Cardiothorac Vasc Anesth; 2020 Nov; 34(11):2921-2927. PubMed ID: 32620484
[TBL] [Abstract][Full Text] [Related]
13. Real time measurement of heparin concentration during cardiopulmonary bypass.
Hashimoto K; Sasaki T; Hachiya T; Takakura H; Onoguchi K; Nagahori R; Takeuchi S
J Cardiovasc Surg (Torino); 1999 Oct; 40(5):645-51. PubMed ID: 10596996
[TBL] [Abstract][Full Text] [Related]
14. Transition from Hemochron Response to Hemochron Signature Elite Activated Clotting Time Devices in a Congenital Cardiac Surgery Practice.
Matte GS; Howe RJ; Ibla J; Emani S; Emani SM
J Extra Corpor Technol; 2019 Dec; 51(4):221-226. PubMed ID: 31915405
[TBL] [Abstract][Full Text] [Related]
15. A comparative analysis of four activated clotting time measurement devices in cardiac surgery with cardiopulmonary bypass.
Li H; Serrick C; Rao V; Yip PM
Perfusion; 2021 Sep; 36(6):610-619. PubMed ID: 32885714
[TBL] [Abstract][Full Text] [Related]
16. Hemostasis management by use of Hepcon/HMS: increased bleeding without increased need for blood transfusion.
Beholz S; Grubitzsch H; Bergmann B; Wollert HG; Eckel L
Thorac Cardiovasc Surg; 1999 Oct; 47(5):322-7. PubMed ID: 10599961
[TBL] [Abstract][Full Text] [Related]
17. Measurement of heparin concentration in whole blood with the Hepcon/HMS device does not agree with laboratory determination of plasma heparin concentration using a chromogenic substrate for activated factor X.
Hardy JF; Bélisle S; Robitaille D; Perrault J; Roy M; Gagnon L
J Thorac Cardiovasc Surg; 1996 Jul; 112(1):154-61. PubMed ID: 8691862
[TBL] [Abstract][Full Text] [Related]
18. Heparin concentration-based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements.
Garvin S; FitzGerald DC; Despotis G; Shekar P; Body SC
Anesth Analg; 2010 Oct; 111(4):849-55. PubMed ID: 19861367
[TBL] [Abstract][Full Text] [Related]
19. Heparin detection by the activated coagulation time: a comparison of the sensitivity of coagulation tests and heparin assays.
Murray DJ; Brosnahan WJ; Pennell B; Kapalanski D; Weiler JM; Olson J
J Cardiothorac Vasc Anesth; 1997 Feb; 11(1):24-8. PubMed ID: 9058215
[TBL] [Abstract][Full Text] [Related]
20. Bedside coagulometry during intravenous heparin therapy after coronary angioplasty.
Schroeder AP; Knudsen LL; Husted SE; Knudsen L; Ingerslev J
J Thromb Thrombolysis; 2001 Oct; 12(2):157-63. PubMed ID: 11729367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
